Loading...
XTAE
SEMG
Market cap25mUSD
May 12, Last price  
279.00ILS
1D
4.18%
1Q
-11.43%
Name

Seach Medical Group Ltd

Chart & Performance

D1W1MN
XTAE:SEMG chart
No data to show
P/E
—
P/S
61.36
EPS
—
Div Yield, %
—
Shrs. gr., 5y
8.18%
Rev. gr., 5y
51.96%
Revenues
150m
+12.01%
2,004,0008,968,00012,302,00018,549,00028,834,00036,802,00067,340,000134,210,000150,324,000
Net income
-11m
L+208.15%
-5,356,0001,579,0002,957,0008,015,000-22,554,00011,967,0005,349,000-3,411,000-10,511,000
CFO
225k
-98.71%
-3,167,000627,0001,770,0003,707,000828,000-5,752,000-8,128,00017,394,000225,000

Profile

Seach Medical Group Ltd manufactures and sells medicinal cannabis products worldwide. The company offers medicinal cannabis inflorescence and oil compounds under the Nitzan brand name. It also provides power powder and moodpicks. Seach Medical Group Ltd was founded in 2002 and is based in Ramat Gan, Israel.
URL
https://seach.co.il/
IPO date
May 21, 1990
Employees
145
Domiciled in
IL
Incorporated in
IL

Valuation

Title
ILS in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
150,324
12.01%
134,210
99.30%
Cost of revenue
152,921
130,099
Unusual Expense (Income)
NOPBT
(2,597)
4,111
NOPBT Margin
3.06%
Operating Taxes
1,592
1,203
Tax Rate
29.26%
NOPAT
(4,189)
2,908
Net income
(10,511)
208.15%
(3,411)
-163.77%
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
8,114
5,821
Long-term debt
31,991
42,781
Deferred revenue
20,387
Other long-term liabilities
1,311
(19,003)
Net debt
26,482
21,722
Cash flow
Cash from operating activities
225
17,394
CAPEX
(891)
(1,235)
Cash from investing activities
(5,718)
(10,217)
Cash from financing activities
(6,320)
(6,933)
FCF
(4,750)
(7,422)
Balance
Cash
10,374
21,804
Long term investments
3,249
5,076
Excess cash
6,107
20,170
Stockholders' equity
85,760
98,385
Invested Capital
107,177
109,604
ROIC
3.06%
ROCE
3.14%
EV
Common stock shares outstanding
34,024
34,024
Price
Market cap
EV
EBITDA
3,922
10,840
EV/EBITDA
Interest
1,533
Interest/NOPBT
37.29%